Article

Best Practices in Endoscopic Ultrasound-Guided Fine-Needle Aspiration

Division of Gastroenterology-Hepatology, University of Alabama at Birmingham, Birmingham, AL 35249, USA.
Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association (Impact Factor: 6.53). 04/2012; 10(7):697-703. DOI: 10.1016/j.cgh.2012.03.017
Source: PubMed

ABSTRACT Over the past 2 decades, endoscopic ultrasound-guided fine-needle aspiration has evolved to become an indispensable tool for tissue acquisition in patients with gastrointestinal tumors. The technique is useful for biopsy of mucosal and submucosal lesions in which prior endoscopic biopsies have been nondiagnostic; to sample peri-intestinal structures such as lymph nodes; and to sample masses in the pancreas, liver, adrenal glands, gallbladder, and bile duct. Also, with the advent of neoadjuvant therapies for diseases such as pancreatic cancer, most patients require a tissue diagnosis before initiating treatment. This review provides a perspective on technical issues that are key for best practices in endoscopic ultrasound-guided fine-needle aspiration.

0 Followers
 · 
149 Views
 · 
0 Downloads
  • Source
    • "This is usually achieved more often in the transesophageal and transgastric position as opposed to the transduodenal. When targeting the uncinate process or pancreatic neck from the duodenal bulb, the tip of the echoendoscope is flexed, thus making needle passage more difficult.75 Troubleshooting this issue by maneuvering the echoendoscope into the long position may solve the problem, however at the expense of a more precarious scope position. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is one of the least invasive and most effective modality in diagnosing pancreatic adenocarcinoma in solid pancreatic lesions, with a higher diagnostic accuracy than cystic tumors. EUS-FNA has been shown to detect tumors less than 3 mm, due to high spatial resolution allowing the detection of very small lesions and vascular invasion, particularly in the pancreatic head and neck, which may not be detected on transverse computed tomography. Furthermore, this minimally invasive procedure is often ideal in the endoscopic procurement of tissue in patients with unresectable tumors. While EUS-FNA has been increasingly used as a diagnostic tool, most studies have collectively looked at all primary pancreatic solid lesions, including lymphomas and pancreatic neuroendocrine neoplasms, whereas very few studies have examined the diagnostic utility of EUS-FNA of pancreatic ductal carcinoma only. As with any novel and advanced endoscopic procedure that may incorporate several practices and approaches, endoscopists have adopted diverse techniques to improve the tissue procurement practice and increase diagnostic accuracy. In this article, we present a review of literature to date and discuss currently practiced EUS-FNA technique, including indications, technical details, equipment, patient selection, and diagnostic accuracy.
    09/2013; 46(5):552-562. DOI:10.5946/ce.2013.46.5.552
  • Source
    • "In a recent European study, the diagnostic accuracy was greater than 90% using this new 19-gauge EUS-FNB needle.20 The 22- and 25-gauge needles are also available.21 However, further studies are needed to validate this approach in subepithelial lesions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Subepithelial lesions are frequently encountered and remain a diagnostic challenge. Imaging of subepithelial lesions using endoscopic ultrasound (EUS) can be helpful in narrowing the differential diagnosis of the lesion; however, definitive diagnosis typically requires tissue. Many methods for acquiring tissue exist including EUS-guided fine needle aspiration, Trucut biopsy, and fine needle biopsy. Obtaining adequate tissue is important for cytologic and histologic exams including immunohistochemical stains, thus a great deal of effort has been made to increase tissue acquisition in order to improve diagnostic yield in subepithelial lesions.
    09/2013; 46(5):441-444. DOI:10.5946/ce.2013.46.5.441
  • Source
    • "In a European study, histologic samples that were obtained with this new 19 G EUS-FNB needle showed diagnostic accuracy of more than 90%.25 The 22 G FNB device for transduodenal approach is also available.26 "
    [Show abstract] [Hide abstract]
    ABSTRACT: A submucosal lesion, more appropriately a subepithelial lesion, is hard to diagnose. Endoscopic ultrasonography is good to differentiate the nature of submucosal lesion. For definite diagnosis, tissue acquisition from submucosal lesion is necessary, and many methods have been introduced for this purpose mainly by endoscopic ultrasonography, such as endoscopic ultrasound-guided fine needle aspiration (EUS-FNA), EUS-guided Trucut Biopsy (TCB), and EUS-guided fine needle biopsy (FNB). For EUS-FNA, adequate processing of specimen is important, and for proper diagnosis of EUS-FNA specimen, both cytologic and histologic examinations, including immunohistochemical stains, are important. All gastrointestinal stromal tumors have some degree of malignant potential, so there have been a lot of efforts and methods to increase diagnostic yields of submucosal lesion. We herein review the current hot topics on EUS-FNA for submucosal tumor, such as needles, on-site cytopathologists, immunohistochemical stains, EUS-TCB, EUS-FNB, Ki-67 labelling index, DOG1, and combining EUS-FNA and EUS-TCB.
    06/2012; 45(2):117-23. DOI:10.5946/ce.2012.45.2.117
Show more